Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis
In The Last Decade
doi.org/10.1086/520980 →Countries where authors are citing Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis
This map shows the geographic impact of Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis more than expected).
Fields of papers citing Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis
This network shows the impact of Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis.
About Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis
This paper, published in 2007, received 478 indexed citations . Written by Peter G. Pappas, Robert F. Betts, Márcio Nucci, Deepak Talwar, Jan J. De Waele, José A. Vázquez, B Dupont, David L. Horn, Luis Ostrosky‐Zeichner and Annette C. Reboli covering the research area of Pharmacology, Epidemiology and Infectious Diseases. It is primarily cited by scholars working on Infectious Diseases (447 citations), Epidemiology (354 citations) and Pharmacology (68 citations).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1086/520980.